Sakar Healthcare (NSE:SAKAR) Common Stock: ₹222 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SAKAR Sakar Healthcare Ltd NSE:SAKAR
67 GF Score
Price ₹827.60
GF Value ₹543.76
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sakar Healthcare Common Stock?

Sakar Healthcare NSE:SAKAR -1.15% 67 Common Stock is ₹222 Mil as of Mar. 2026. GuruFocus rates NSE:SAKAR with a GF Score™ of 67/100 and a GF Value™ of ₹543.76 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Sakar Healthcare's quarterly common stock declined from Sep. 2025 (₹222 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹222 Mil).

Sakar Healthcare's annual common stock increased from Mar. 2024 (₹217 Mil) to Mar. 2025 (₹219 Mil) and increased from Mar. 2025 (₹219 Mil) to Mar. 2026 (₹222 Mil).

Sakar Healthcare Common Stock Historical Data

* Premium members only.

The historical data trend for Sakar Healthcare's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sakar Healthcare Common Stock Chart

Sakar Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 171.18 190.40 217.50 219.50 222.50

Sakar Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 219.50 0.00 222.50 0.00 222.50
NSE:SAKAR
67GF Score
Sakar Healthcare Ltd NSE:SAKAR
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sakar Healthcare Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹222 Mil mean?
Sakar Healthcare (NSE:SAKAR) has a Common Stock of ₹222 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Sakar Healthcare and its competitors.
Is Sakar Healthcare's Common Stock too high?
Sakar Healthcare's current Common Stock is ₹222 Mil. Overall, Sakar Healthcare has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sakar Healthcare's Common Stock compare to ZTS and UTHR?
Sakar Healthcare's Common Stock of ₹222 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Sakar Healthcare and its competitors. Sakar Healthcare's current Common Stock is ₹222 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sakar Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sakar Healthcare (NSE:SAKAR) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹543.76, compared to a current price of ₹827.60 — trading 52.2% above its estimated fair value. The current Common Stock is ₹222 Mil. Sakar Healthcare's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Sakar Healthcare (NSE:SAKAR), the current Common Stock is ₹222 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sakar Healthcare (NSE:SAKAR) Overvalued in 2026?

Based on GuruFocus' analysis, Sakar Healthcare stock appears to be overvalued. The current stock price of ₹827.60 is trading 52.2% above its estimated GF Value™ of ₹543.76. GuruFocus considers Sakar Healthcare to be Significantly Overvalued.

Key valuation signals for NSE:SAKAR:

  • Common Stock: ₹222 Mil
  • GF Value™: ₹543.76 vs. price of ₹827.60 (52.2% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the NSE:SAKAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sakar Healthcare Business Description

Address 406, Silver Oaks Comm. Complex, Opposite Arun Society, Paldi, Ahmedabad, GJ, IND, 382 007
Sakar Healthcare Ltd is engaged in manufacturing Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections. The company offers its products to Sri Lanka, the Philippines, Vietnam, Cambodia, Sudan, Myanmar, Mauritius, Costa Rica, Panama, El Salvador and Paraguay.
67GF Score

Get the complete analysis for NSE:SAKAR

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹827.60
Price
₹543.76
GF Value